Form 8-K - Current report:
SEC Accession No. 0001564590-21-055751
Filing Date
2021-11-09
Accepted
2021-11-09 16:24:05
Documents
14
Period of Report
2021-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lyra-8k_20211109.htm   iXBRL 8-K 38483
2 EX-99.1 lyra-ex991_15.htm EX-99.1 240318
3 GRAPHIC gsyrymio0t0x000001.jpg GRAPHIC 25556
  Complete submission text file 0001564590-21-055751.txt   458789

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA lyra-20211109.xsd EX-101.SCH 5701
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE lyra-20211109_lab.xml EX-101.LAB 19323
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lyra-20211109_pre.xml EX-101.PRE 11495
7 EXTRACTED XBRL INSTANCE DOCUMENT lyra-8k_20211109_htm.xml XML 3540
Mailing Address 480 ARSENAL STREET WATERTOWN MA 02472
Business Address 480 ARSENAL STREET WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39273 | Film No.: 211392571
SIC: 3841 Surgical & Medical Instruments & Apparatus